Results 191 to 200 of about 49,507 (253)
Some of the next articles are maybe not open access.

Antithrombin III metabolism in two colitis patients with acquired antithrombin III deficiency

Gastroenterology, 1985
125I-Antithrombin III metabolism studies were performed in 2 patients with ischemic and ulcerative colitis, respectively. Both patients had acquired antithrombin III deficiency and objectively diagnosed deep venous thrombosis. A decreased 125I-antithrombin III plasma disappearance halflife and an increased fractional catabolic rate was found in both ...
Knot, E. A.   +4 more
openaire   +3 more sources

Antithrombin III concentrate: its catabolism in health and in antithrombin III deficiency

Scandinavian Journal of Clinical and Laboratory Investigation, 1981
The catabolism of purified radiolabelled antithrombin III (AT III) concentrate was studied in two normals and two patients with congenital AT III deficiency both alone and combined with warfarin. The radiolabelling with iodine monochloride did not change the quality of the concentrate. The half-life varied between 3.4 and 4.8 days.
L, Tengborn   +3 more
openaire   +2 more sources

Thrombosis in Antithrombin-III Deficiency

Annals of Internal Medicine, 1992
Excerpt To the Editors:Demers and colleagues (1) reported on the prevalence of thrombosis in antithrombin-III-deficient patients.
Valerio De Stefano, Giuseppe Leone
openaire   +1 more source

Antithrombin III deficiency in pregnancy

Primary Care Update for OB/GYNS, 1999
Abstract Thromboembolism is one of the most significant and common medical problems occurring during pregnancy. Some pregnant women are at a higher risk of thromboembolism because of inheritable hypercoagulable states. Antithrombin III deficiency is one of the inheritable coagulable states that may lead to an increase in thromboembolism during ...
Laurie S Swaim, Larry C Gilstrap
openaire   +1 more source

Replacement Therapy in Antithrombin III Deficiency

Transfusion Medicine Reviews, 1989
NTITHROMBIN III (ATIll) has two impor­ tant roles in hemostasis; it is the predomi­ nant circulating inhibitor of clotting factors acti­ vated during blood coagulation, and the major heparin cofactor in plasma. 1 Its key modulatory function is clearly illustrated by the long-recog­ nized causal relationship between inherited an­ tithrombin deficiency ...
openaire   +2 more sources

Antithrombin III replacement in animal models of acquired antithrombin III deficiency

Blood Coagulation & Fibrinolysis, 1994
Plasma antithrombin III (AT III) levels decrease early during Gram-negative septicaemia, and even a moderate decrease in this major inhibitor of the coagulation system is associated with serious disseminated intravascular coagulation (DIC). This study reports the efficacy of high dose (at least 250 units/kg) AT III replacement in three animal models of
openaire   +2 more sources

Familial antithrombin III deficiency.

British medical journal, 1978
H A de Haas   +3 more
  +5 more sources

Acquired antithrombin III deficiency and thrombosis in the nephrotic syndrome.

American Journal of Medicine, 1978
R. Kauffmann   +3 more
semanticscholar   +1 more source

Antithrombin III Deficiency and Thromboembolism

Clinics in Haematology, 1981
E, Thaler, K, Lechner
openaire   +2 more sources

Home - About - Disclaimer - Privacy